XOMA Royalty (XOMA) Profit After Tax (2011 - 2026)
XOMA Royalty's (XOMA) quarterly Profit After Tax came in at $4.5 million in Q1 2026, up 88.64% year-on-year from $2.4 million in Q1 2025, and down 26.84% quarter-over-quarter from $6.1 million in Q4 2025.
XOMA Royalty (XOMA) Profit After Tax (2011 - 2026) Analysis & Trends
XOMA Royalty has disclosed Profit After Tax across 16 years of filings, most recently posting $4.5 million for Q1 2026.
- Profit After Tax for Q1 2026 came in at $4.5 million, up 88.64% year-over-year; the trailing twelve-month figure through Mar 2026 was $33.8 million (up 1282.58% YoY), and the FY2025 annual result was $31.7 million, up 329.45% from the prior year.
- Profit After Tax came in at $4.5 million for Q1 2026 at XOMA Royalty, down from $6.1 million in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of $16.0 million in Q2 2024 to a low of -$20.1 million in Q4 2023.
- The 5-year median for Profit After Tax is -$4.2 million (2022), against an average of -$2.1 million.
- Across the five-year window, Profit After Tax sank 330.39% in 2023 and surged 396.02% in 2024, its largest moves.
- XOMA Royalty's Profit After Tax stood at -$6.0 million in 2022, then slumped by 236.5% to -$20.1 million in 2023, then soared by 80.27% to -$4.0 million in 2024, then soared by 253.81% to $6.1 million in 2025, then retreated by 26.84% to $4.5 million in 2026.
- The last three Profit After Tax figures came in at $4.5 million (Q1 2026), $6.1 million (Q4 2025), and $14.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 30.90 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | -14.46 Mn |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | -3.63 Mn |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | -753,254.00 |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 1.03 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | -56.74 Mn |
| 10 | XOMA Royalty | 5.52 Mn | -60.56 Mn | - | 4.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.47 Mn |
| Dec 31, 2025 | 6.10 Mn |
| Sep 30, 2025 | 14.05 Mn |
| Jun 30, 2025 | 9.19 Mn |
| Mar 31, 2025 | 2.37 Mn |
| Dec 31, 2024 | -3.97 Mn |
| Sep 30, 2024 | -17.24 Mn |
| Jun 30, 2024 | 15.99 Mn |
| Mar 31, 2024 | -8.60 Mn |
| Dec 31, 2023 | -20.11 Mn |
| Sep 30, 2023 | -5.51 Mn |
| Jun 30, 2023 | -5.40 Mn |
| Mar 31, 2023 | -9.81 Mn |
| Dec 31, 2022 | -5.98 Mn |
| Sep 30, 2022 | -4.18 Mn |
| Jun 30, 2022 | -4.67 Mn |
| Mar 31, 2022 | -2.28 Mn |
| Dec 31, 2021 | 29.84 Mn |
| Sep 30, 2021 | -4.44 Mn |
| Jun 30, 2021 | -2.24 Mn |